Astria Therapeutics (ATXS) Stock Chart & Stock Price History $5.81 +0.08 (+1.40%) As of 02:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Astria Therapeutics Stock Price Performance The Astria Therapeutics (ATXS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 35.44%, with a year-to-date return of -35.01%. In the past month, the stock has increased 17.14%, reflecting recent market activity. As of the latest close, Astria Therapeutics traded at $5.73 with a market cap of $323.34 million and volume of 218,536 shares. Five years ago, the stock traded at a split-adjusted price of $38.46, representing a 84.89% decrease over that period. At the time, it had a market cap of $115.08 million and a volume of 155,400 shares. Receive ATXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.31%1 Month Performance+17.14%3 Month Performance+12.82%Year-To-Date Performance-35.01%1 Year Performance-35.44%5 Year Performance-84.89% ATXS Stock Chart for Thursday, July, 3, 2025 ATXS Chart by TradingView Astria Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$5.43$5.73+5.52%$5.91$5.43218,536 shs$323.34 million07/01/2025$5.36$5.43+1.31%$5.71$5.26297,420 shs$306.42 million06/30/2025$5.57$5.36-3.77%$5.68$5.36232,048 shs$302.49 million06/27/2025$5.44$5.57+2.39%$5.64$5.411.35 million shs$314.32 million06/26/2025$5.65$5.44-3.72%$5.64$5.25213,732 shs$306.98 million06/25/2025$5.76$5.65-1.91%$5.79$5.48179,715 shs$318.83 million06/24/2025$5.61$5.76+2.67%$5.77$5.60199,361 shs$325.04 million06/23/2025$5.86$5.61-4.27%$5.91$5.41160,418 shs$316.57 million06/20/2025$5.89$5.86-0.51%$6.13$5.75470,476 shs$330.68 million06/19/2025$5.89$5.89$5.96$5.49373,673 shs$332.37 million Get the Latest News and Ratings for ATXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$5.70$5.89+3.33%$5.96$5.49373,673 shs$332.37 million06/17/2025$5.93$5.70-3.88%$5.89$5.43522,470 shs$321.67 million06/16/2025$5.72$5.93+3.67%$5.96$5.58251,340 shs$334.65 million06/13/2025$5.60$5.72+2.14%$5.97$5.37346,240 shs$322.80 million06/12/2025$5.79$5.60-3.28%$5.84$5.56295,348 shs$316.03 million06/11/2025$5.71$5.79+1.40%$5.94$5.53363,816 shs$326.75 million06/10/2025$5.79$5.71-1.38%$5.94$5.69320,659 shs$322.24 million06/09/2025$5.99$5.79-3.34%$6.12$5.51306,555 shs$326.75 million06/06/2025$5.22$5.99+14.75%$6.09$5.28664,913 shs$338.04 million06/05/2025$5.28$5.22-1.14%$5.43$5.09282,610 shs$294.59 million06/04/2025$4.96$5.28+6.45%$5.43$4.92293,144 shs$297.97 million06/03/2025$4.78$4.96+3.77%$5.19$4.78456,271 shs$279.91 million06/02/2025$4.64$4.78+3.02%$4.87$4.65309,726 shs$269.76 million Related Companies Ocular Therapeutix Stock Chart Travere Therapeutics Stock Chart BGM Group Stock Chart Structure Therapeutics Stock Chart CureVac Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Dyne Therapeutics Stock Chart Amphastar Pharmaceuticals Stock Chart Niagen Bioscience Stock Chart Aurinia Pharmaceuticals Stock Chart Receive ATXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATXS) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATXS Stock Alerts